Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.
| Distributed by / for | Sandoz Inc., Princeton, NJ 08540 |
| NDC | 66758-008-01 |
| Full product label | Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540. |
| Recalling firm | Sandoz Inc |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 32,099 cartons |
| Recall initiated | 2016-08-24 |
| Report date | 2016-09-28 |
| Recall completed | 2017-07-12 |
| Recall number | D-1513-2016 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗